Pfizer

Overview

Founded Date March 16, 2002
Sectors Telecom
Posted Jobs 0
Viewed 5

Company Description

Erectile Dysfunction Drugs could help Treat Oesophageal Cancer, Study Finds

Erectile dysfunction drugs could assist deal with oesophageal cancer, study discovers

22 June 2022

A component in impotence medication may assist deal with oesophageal cancer, a study has discovered.

Southampton scientists found the PDE5 inhibitors in the medication helped permeate the barrier of cells around tumours, making it possible for chemotherapy drugs to reach cancer cells.

One in 10 patients presently survives the disease, which is discovered anywhere in the gullet, for 10 years or more.

The study was funded by Cancer Research UK. The next phase is a medical trial.

Prof Tim Underwood, lead author of the study, stated the discovery could improve these survival rates.

He said a cell understood as the cancer-associated fibroblast, accountable for injury recovery, could be targeted with the inhibitors.

“It’s been utilized throughout the world in countless dosages,” he explained. “It’s safe, and we applied it to cancer.”

He included it was to the researchers “wonder and surprise and pleasure” that the drug had an impact.

“We require to put this into a medical trial where we attempt the drug type alongside chemotherapy to see if it makes the chemotherapy more efficient,” he stated.

“The initial work suggests it must do, and if it does and if it’s safe, and it improves results of chemotherapy, then it could be actually significant for the patients I look after.”

The research study was brought out utilizing tumours from eight cancer patients, with further tests done on mice.

Chemotherapy just helps 20% of patients in a significant method, he said.

“If this drug mix even improves it by a percentage, we’re truly going to help a large number of people every year to react much better and live longer.”

Researchers at Southampton University Hospitals say that the usual results of erectile dysfunction disorder drugs require additional stimulation, so would not affect cancer patients in the same way.

Prof Underwood said the main side effects would be “a bit of headache, a bit of flushing”.

Terry Daly, from Aldershot, Hampshire, is among the 9,500 people detected with oesophageal cancer in the UK every year.

It often goes unnoticed in the early phases, with Mr Daly discovering it was tough to swallow his food and he wound up regurgitating it.

He is quickly to undergo another round of chemotherapy, and said if he had the option to take the new treatment he would have “taken it with both hands”.

“The research that is being done is absolutely great,” he stated.

“It is simply unbelievable that there are people out there happy to invest their lives just searching for a treatment, so that people can get on with their everyday lives and not have to go through all this things.

“You can’t thank these people enough for what they’re doing.”

The five-year research study has been moneyed by Cancer Research UK and the Medical Research Council.

A clinical trial is expected within the next 18 months and if successful, it is hoped brand-new treatments based on this research could be used within 10 years.

Follow BBC South on Facebook, external, Twitter, external, or Instagram, external. Send your story ideas to south.newsonline@bbc.co.uk, external.

Related subjects

Aldershot

Southampton

Cancer

We had the very same cancer as Andy Goram

31 May 2022

Lorry driver’s ‘ticking time-bomb’ cancer gene